CURA
Curaleaf Q4 2018 Earnings – Strong Performance Comes at a Premium
Curaleaf (CNSX: CURA) reported strong 2018 numbers, clearly indicating they are set to dominate U.S. marijuana in 2019. Is the…
Curaleaf to Acquire Acres Cannabis in $70 Million Deal
Seeking additional vertical integration in Nevada, Curaleaf Holdings, Inc. (CSE: CURA; OTCQX: CURLF) this week entered an agreement to acquire Las…
Green Growth’s Formal Aphria Offer is Lacking – Highlights Valuation Disconnect
The Green Growth offer significantly undervalues Aphria. Investors should feel comfortable owning the company as a standalone future cash flow…
U.S. Marijuana Scorecard (Winter 2019)
What is the Marijuana Scorecard? The marijuana scorecard is a tool investors can use to judge which U.S. marijuana companies are…
iAnthus Q3 2018 Earnings Review – Patience is a Virtue
Bottom Line iAnthus is the poster child for a company in transition. Management has proven themselves to be financially agile and…
The Grizzle and CB1 Guide to US Cannabis Stocks
Grizzle and CB1 Capital present this comprehensive guide to publicly traded U.S. cannabis companies. All the players, valuations and facts…
GMP Slashes Canopy Estimates – More Noise than Signal
Big Revenue Change from a Big Cannabis Broker GMP Securities, the go-to bank for the cannabis industry, downgraded its 2019…